Science
Mechanism of Action
The efficacy of Coptis Chinensis Rhizome Extract is primarily attributed to key alkaloids such as berberine and coptisine. Berberine inhibits the expression of proinflammatory cytokines and cell surface molecules, alongside blocking LPS-induced monocyte chemoattractant protein (MCP)-1 production via AP-1 and NFkB pathways. Both alkaloids contribute to its antiseptic actions against bacteria like *Staphylococcus aureus* and fungi including *Candida* species. Furthermore, it acts as an antioxidant by modulating oxidative stress, with coptisine specifically up-regulating protective pathways such as NF-κB, MAPK, PI3K/Akt, NLRP3 inflammasome, ERK, JNK, p38, NQO1, Nrf2, and Akt.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Demonstrated effectiveness in external applications for treating conditions such as burns, acne, skin ulcers, neurodermatitis, and various forms of eczema.
- 02 Shown to ameliorate radiation-induced skin injury in a rat model through the modulation of oxidative stress.
- 03 Exhibits significant anti-inflammatory, antimicrobial (effective against *Staphylococcus aureus* and *Candida* species), and antifungal properties.
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
No specific safety assessments for topical use have been conducted by CIR, SCCS, or FDA. Berberine, a significant constituent, is identified as a primary toxic component, necessitating further research into its toxicological profile and target organs. Some individuals may experience allergic reactions.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Coptis Chinensis Rhizome Extract is a valuable ingredient, offering broad-spectrum benefits including significant anti-inflammatory, antimicrobial, and antioxidant actions, though further safety assessment for topical concentrations is warranted.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources